A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Finding the right balance between safety and returns isn’t easy, which is why StockStory is here to help. Keeping that in mind, here is one low-volatility stock that could succeed under all market conditions and two that may not deliver the returns you need.
Two Stocks to Sell:
SS&C (SSNC)
Rolling One-Year Beta: 0.74
Founded in 1986 as a bridge between technology and financial services, SS&C Technologies (NASDAQ: SSNC) provides software and software-enabled services that help financial firms and healthcare organizations automate complex business processes.
Why Do We Think Twice About SSNC?
- Costs have risen faster than its revenue over the last five years, causing its adjusted operating margin to decline by 1.4 percentage points
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 2.6 percentage points
- ROIC of 6.6% reflects management’s challenges in identifying attractive investment opportunities
SS&C’s stock price of $75.27 implies a valuation ratio of 11.1x forward P/E. Check out our free in-depth research report to learn more about why SSNC doesn’t pass our bar.
First Busey (BUSE)
Rolling One-Year Beta: 0.82
Tracing its roots back to 1868 during America's post-Civil War reconstruction era, First Busey (NASDAQ: BUSE) is a bank holding company that provides commercial and retail banking, wealth management, and payment technology solutions across Illinois, Missouri, Florida, and Indiana.
Why Does BUSE Give Us Pause?
- Inferior net interest margin of 3.3% means it must compensate for lower profitability through increased loan originations
- Annual earnings per share growth of 4.9% underperformed its revenue over the last five years, showing its incremental sales were less profitable
- Projected tangible book value per share decline of 3.2% for the next 12 months points to tough credit quality challenges ahead
At $26.90 per share, First Busey trades at 1x forward P/B. If you’re considering BUSE for your portfolio, see our FREE research report to learn more.
One Stock to Watch:
Cigna (CI)
Rolling One-Year Beta: 0.11
With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE: CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.
Why Could CI Be a Winner?
- Annual revenue growth of 18.6% over the last two years was superb and indicates its market share increased during this cycle
- Enormous revenue base of $274.7 billion gives it leverage over plan holders and advantageous reimbursement terms with healthcare providers
- Earnings per share grew by 10.1% annually over the last five years, comfortably beating the peer group average
Cigna is trading at $286.56 per share, or 9.7x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
